These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8576297

  • 1. Predictive performance of four pharmacokinetic methods for calculating digoxin dosage.
    el-Sayed YM.
    J Clin Pharm Ther; 1995 Oct; 20(5):297-304. PubMed ID: 8576297
    [Abstract] [Full Text] [Related]

  • 2. Can available mathematical models predict serum digoxin levels in Thai patients?
    Jiratham-Opas J, Kanjanavanit R, Wongcharoen W, Punyawudho B, Arunmanakul P, Amaritakomol A, Topaiboon P, Gunaparn S, Phrommintikul A.
    J Clin Pharm Ther; 2018 Jun; 43(3):377-384. PubMed ID: 29365353
    [Abstract] [Full Text] [Related]

  • 3. Predictive performance of serum digoxin concentration in patients with congestive heart failure by a hyperbolic model based on creatinine clearance.
    Konishi H, Shimizu S, Chiba M, Minouchi T, Koida M, Yamaji A.
    J Clin Pharm Ther; 2002 Aug; 27(4):257-65. PubMed ID: 12174027
    [Abstract] [Full Text] [Related]

  • 4. Correlation coefficient versus prediction error in assessing the accuracy of digoxin dosing methods.
    Lalonde RL, Pao D.
    Clin Pharm; 1984 Aug; 3(2):178-83. PubMed ID: 6723224
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic accuracy of a hyperbolic model in predicting digoxin concentrations based on glomerular filtration rates.
    González-López J, Tutor JC.
    Nefrologia; 2011 Aug; 31(5):573-8. PubMed ID: 21959724
    [Abstract] [Full Text] [Related]

  • 6. [Effect of itraconazole on digoxin clearance in patients with congestive heart failure].
    Wakasugi H, Ishizuka R, Koreeda N, Yano I, Futami T, Nohara R, Sasayama S, Inui K.
    Yakugaku Zasshi; 2000 Sep; 120(9):807-11. PubMed ID: 11019654
    [Abstract] [Full Text] [Related]

  • 7. Population-based investigation of relative clearance of digoxin in Japanese neonates and infants by multiple-trough screen analysis.
    Suematsu F, Yukawa E, Yukawa M, Minemoto M, Ohdo S, Higuchi S, Goto Y.
    Eur J Clin Pharmacol; 2001 Apr; 57(1):19-24. PubMed ID: 11372585
    [Abstract] [Full Text] [Related]

  • 8. The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure.
    Harjola VP, Oikarinen L, Toivonen L, Jurkko R, Puttonen J, Sarapohja T, Sundberg S, Nieminen MS.
    Int J Clin Pharmacol Ther; 2008 Aug; 46(8):389-99. PubMed ID: 18793580
    [Abstract] [Full Text] [Related]

  • 9. Use of a simplified nomogram to individualize digoxin dosing versus standard dosing practices in patients with heart failure.
    DiDomenico RJ, Bress AP, Na-Thalang K, Tsao YY, Groo VL, Deyo KL, Patel SR, Bishop JR, Bauman JL.
    Pharmacotherapy; 2014 Nov; 34(11):1121-31. PubMed ID: 25164709
    [Abstract] [Full Text] [Related]

  • 10. Population-based investigation of relative clearance of digoxin in Japanese patients by multiple trough screen analysis: an update.
    Yukawa E, Honda T, Ohdo S, Higuchi S, Aoyama T.
    J Clin Pharmacol; 1997 Feb; 37(2):92-100. PubMed ID: 9055134
    [Abstract] [Full Text] [Related]

  • 11. A method of determining the dose of digoxin for heart failure in the modern era.
    Bauman JL, DiDomenico RJ, Viana M, Fitch M.
    Arch Intern Med; 1997 Feb; 166(22):2539-45. PubMed ID: 17159022
    [Abstract] [Full Text] [Related]

  • 12. Direct comparison of three methods for predicting digoxin concentrations.
    Williams PJ, Lane JR, Capparelli EV, Kim YH, Coleman R.
    Pharmacotherapy; 1996 Feb; 16(6):1085-92. PubMed ID: 8947982
    [Abstract] [Full Text] [Related]

  • 13. Efficiency of individual dosage of digoxin with calculated concentration.
    Zhao L, Yang P, Li P, Wang X, Qin W, Zhang X.
    Clin Interv Aging; 2014 Feb; 9():1205-10. PubMed ID: 25092970
    [Abstract] [Full Text] [Related]

  • 14. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW, Charland SL, Shaw LM, Kobrin S, Goldfarb S, Stanek EJ, Spinler SA.
    Pharmacotherapy; 1997 Feb; 17(3):584-90. PubMed ID: 9165563
    [Abstract] [Full Text] [Related]

  • 15. Effect of exenatide on the steady-state pharmacokinetics of digoxin.
    Kothare PA, Soon DK, Linnebjerg H, Park S, Chan C, Yeo A, Lim M, Mace KF, Wise SD.
    J Clin Pharmacol; 2005 Sep; 45(9):1032-7. PubMed ID: 16100297
    [Abstract] [Full Text] [Related]

  • 16. Population pharmacokinetics of digoxin in Japanese patients: a 2-compartment pharmacokinetic model.
    Yukawa E, Suematu F, Yukawa M, Minemoto M, Ohdo S, Higuchi S, Goto Y, Aoyama T.
    Clin Pharmacokinet; 2001 Sep; 40(10):773-81. PubMed ID: 11707062
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic interaction of sparfloxacin and digoxin.
    Johnson RD, Dorr MB, Hunt TL, Conway S, Talbot GH.
    Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
    [Abstract] [Full Text] [Related]

  • 19. Effect of troglitazone on steady-state pharmacokinetics of digoxin.
    Loi CM, Knowlton PW, Stern R, Randinitis EJ, Vassos AB, Koup JR, Sedman AJ.
    J Clin Pharmacol; 1998 Feb; 38(2):178-83. PubMed ID: 9549650
    [Abstract] [Full Text] [Related]

  • 20. Population analysis for the optimization of digoxin treatment in Japanese paediatric patients.
    Suematsu F, Minemoto M, Yukawa E, Higuchi S.
    J Clin Pharm Ther; 1999 Jun; 24(3):203-8. PubMed ID: 10438180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.